Team is advising Global Top 25 Pharmaceutical and Biotech Company on various legal aspects of medicines pricing, procurement and reimbursement reform, introduction of the National Essential Medicines List and expected transformation in state funding of rare diseases treatment. link

Marchenko Danevych has successfully defended a group trading subsidiary of one of the Top 5 Global pharmaceutical companies in the competition case conducted by the Antimonopoly Committee of Ukraine. link

Marchenko Danevych advised one of the Top 5 Global pharmaceutical companies on the dispute resolution strategy to challenge unfair competition practices of a competing undertaking controlled by Ukrainian and U.S. investors. link

Marchenko Danevych has been acting for a Top 10 Global pharmaceutical company in the domestic litigation with the Ministry of Health of Ukraine and in the related investor-state dispute. link

Our lawyers acted for a global pharmaceutical company in an unfair competition dispute initiated by a competing undertaking concerning Ukrainian operations and supplies of medical devices. link

Marchenko Danevych lawyers successfully defended apharmaceutical company in an investigation conducted by the Ukrainian antitrust authority. link

This site uses cookies. An explanation of their purpose can be found within Terms of Use